1-8 of 8
Authors: Igor T. Gavrilovic
Sort by
Journal Article
ACCEPTED MANUSCRIPT
Phase Ib study with expansion of ibrutinib, lenalidomide and rituximab in patients with relapsed/refractory CNS lymphoma
Get access
Lauren R Schaff and others
Neuro-Oncology, noaf104, https://doi.org/10.1093/neuonc/noaf104
Published: 22 April 2025
Journal Article
CTNI-62. LONG-TERM EFFICACY AND SAFETY OF LAROTRECTINIB IN PATIENTS WITH TROPOMYOSIN RECEPTOR KINASE (TRK) FUSION PRIMARY CENTRAL NERVOUS SYSTEM (CNS) TUMORS Free
Sébastien Perreault and others
Neuro-Oncology, Volume 24, Issue Supplement_7, November 2022, Page vii87, https://doi.org/10.1093/neuonc/noac209.327
Published: 14 November 2022
Journal Article
NIMG-57. NON-INVASIVE DIAGNOSIS OF IDH-MUTANT BRAINSTEM GLIOMAS Free
Marina Kushnirsky and others
Neuro-Oncology, Volume 24, Issue Supplement_7, November 2022, Pages vii176–vii177, https://doi.org/10.1093/neuonc/noac209.675
Published: 14 November 2022
Journal Article
Efficacy and safety of larotrectinib in TRK fusion-positive primary central nervous system tumors Open Access
François Doz and others
Neuro-Oncology, Volume 24, Issue 6, June 2022, Pages 997–1007, https://doi.org/10.1093/neuonc/noab274
Published: 27 November 2021
Journal Article
CTNI-58. EFFICACY AND SAFETY OF LAROTRECTINIB IN ADULT AND PEDIATRIC PATIENTS WITH TROPOMYOSIN RECEPTOR KINASE (TRK) FUSION-POSITIVE PRIMARY CENTRAL NERVOUS SYSTEM (CNS) TUMORS Free
François Doz and others
Neuro-Oncology, Volume 23, Issue Supplement_6, November 2021, Pages vi73–vi74, https://doi.org/10.1093/neuonc/noab196.283
Published: 12 November 2021
Journal Article
CTNI-55. THE CDK4/6 INHIBITOR ABEMACICLIB IN PATIENTS WITH RECURRENT MENINGIOMA AND OTHER PRIMARY CNS TUMORS Free
Elizabeth Coffee and others
Neuro-Oncology, Volume 23, Issue Supplement_6, November 2021, Pages vi72–vi73, https://doi.org/10.1093/neuonc/noab196.280
Published: 12 November 2021
Journal Article
Clinical trial of proton craniospinal irradiation for leptomeningeal metastases Free
T Jonathan Yang and others
Neuro-Oncology, Volume 23, Issue 1, January 2021, Pages 134–143, https://doi.org/10.1093/neuonc/noaa152
Published: 27 June 2020
Journal Article
Phase II trial of continuous low-dose temozolomide for patients with recurrent malignant glioma
Get access
Antonio Omuro and others
Neuro-Oncology, Volume 15, Issue 2, February 2013, Pages 242–250, https://doi.org/10.1093/neuonc/nos295
Published: 14 December 2012
Advertisement
Advertisement